VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 21 filers reported holding VASCULAR BIOGENICS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $28,000 | +12.0% | 21,000 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | -16.7% | 21,000 | -4.5% | 0.00% | – |
| Q3 2019 | $30,000 | +3.4% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $29,000 | -12.1% | 22,000 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | +57.1% | 22,000 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -41.7% | 22,000 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -26.5% | 22,000 | -0.5% | 0.00% | – |
| Q2 2018 | $49,000 | +25.6% | 22,100 | +30.0% | 0.00% | – |
| Q1 2018 | $39,000 | +333.3% | 17,000 | +750.0% | 0.00% | – |
| Q2 2017 | $9,000 | -18.2% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $11,000 | +10.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | +11.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +28.6% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -36.4% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | -83.6% | 2,000 | -77.8% | 0.00% | -100.0% |
| Q3 2015 | $67,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |